HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
CRISIL reaffirms rating of Cadila Healthcare’s Commercial Paper
Sep-22-2020

Credit rating agency -- CRISIL has, after due deliberations, reaffirmed its A1+ on the Rs 1,300 crore Commercial Paper (enhanced from Rs 250 crore) of Cadila Healthcare. Instruments with this rating are considered to have very strong degree of safety regarding timely payment of financial obligations. Such instruments carry lowest credit risk.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

  RELATED NEWS >>